Gabapentin dose and the 30-day risk of altered mental status in older adults: A retrospective population-based study
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Gabapentin is an effective treatment for chronic neuropathic pain but may cause dizziness, drowsiness, and confusion in some older adults. The goal of this study was to assess the association between gabapentin dosing and adverse outcomes by obtaining estimates of the 30-day risk of hospitalization with altered mental status and mortality in older adults (mean age 76 years) in Ontario, Canada initiated on high dose (>600 mg/day; n = 34,159) compared to low dose (≤600 mg/day; n = 76,025) oral gabapentin in routine outpatient care. A population-based, retrospective cohort study assessing new gabapentin use between 2002 to 2014 was conducted. The primary outcome was 30-day hospitalization with an urgent head computed tomography (CT) scan in the absence of evidence of stroke (a proxy for altered mental status). The secondary outcome was 30-day all-cause mortality. The baseline characteristics measured in the two dose groups were similar. Initiation of a high versus low dose of gabapentin was associated with a higher risk of hospitalization with head CT scan (1.27% vs. 1.06%, absolute risk difference 0.21%, adjusted relative risk 1.29 [95% CI 1.14 to 1.46], number needed to treat 477) but not a statistically significant higher risk of mortality (1.25% vs. 1.16%, absolute risk difference of 0.09%, adjusted relative risk of 1.01 [95% CI 0.89 to 1.14]). Overall, the risk of being hospitalized with altered mental status after initiating gabapentin remains low, but may be reduced through the judicious use of gabapentin, use of the lowest dose to control pain, and vigilance for early signs of altered mental status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skipping, abruptly stopping, or incorrectly taking gabapentoid doses can increase the risk of experiencing adverse symptoms [32].”
From Voice Assistant Reminders and the Latency of Scheduled Medication Use in Older Adults With Pain: Descriptive Feasibility Study (2021) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Vandenbroucke, J. P., Elm, E. V., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010-w1 · Cited by 3,543
Austin, P. C. (2009) · Communications in Statistics - Simulation and Computation · doi:10.1080/03610910902859574 · Cited by 2,445
Backonja, M. (1998) · JAMA · doi:10.1001/jama.280.21.1831 · Cited by 1,533
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & McQuay, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub2 · Cited by 690
Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study
Rice, A. S. C., & Maton, S. (2001) · Pain · doi:10.1016/s0304-3959(01)00407-9 · Cited by 596
Gabapentin: pharmacology and its use in pain management
Rose, M. A., & Kam, P. C. A. (2002) · Anaesthesia · doi:10.1046/j.0003-2409.2001.02399.x · Cited by 535
(2003) · PubMed · Cited by 490
Research works printed but not linked: 3
- TW Post, 2016, Gabapentin Drug Information., UpToDate
- E Von Elm, 2007, 147, 573
- M Backonja, 2003, 25, 81
Cited by
Saur, N. M., Davis, B. R., Montroni, I., Shahrokni, A., Rostoft, S., Russell, M. M., Mohile, S. G., Suwanabol, P. A., Lightner, A. L., Poylin, V. Y., et al. (2022) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000002410 · Cited by 100
Elucidating the Potential Side Effects of Current Anti-Seizure Drugs for Epilepsy
Akyüz, E., Köklü, B., Ozenen, C., Arulsamy, A., & Shaikh, M. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210826125341 · Cited by 93
“In a study examining the effects of high and low dose usage of gabapentin in the elderly, the high dose patients with a history of chronic renal failure had a higher risk of hospitalization with an altered mental state [63, 64].”
BackgroundMujukian, A., Truong, A., Tran, H. P. N., Shane, R. R., Fleshner, P. R., & Zaghiyan, K. N. (2019) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04385-9 · Cited by 54
Seizures and epilepsy in patients with ischaemic stroke
Zöllner, J. P., Schmitt, F. C., Rosenow, F., Kohlhase, K. D., Seiler, A., Strzelczyk, A., & Stefan, H. (2021) · Neurological Research and Practice · doi:10.1186/s42466-021-00161-w · Cited by 54
“Of note, GBP carries the risk of dizziness, vertigo and altered mental status in elderly patients, especially with higher daily doses [35].”
BackgroundRajan, J., & Behrends, M. (2019) · Anesthesiology Clinics · doi:10.1016/j.anclin.2019.04.009 · Cited by 44
Low-Dose Methotrexate and Serious Adverse Events Among Older Adults With Chronic Kidney Disease
Muanda, F. T., Blake, P. G., Weir, M. A., Ahmadi, F., McArthur, E., Sontrop, J. M., Urquhart, B. L., Kim, R. B., & Garg, A. X. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.45132 · Cited by 37
Self-citationRalph, S. J., Weissenberger, A., Bonev, V., King, L., Bonham, M. D., Ferguson, S., Smith, A. D., Goodman-Jones, A. A., & Espinet, A. J. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1709822 · Cited by 35
“It would also seem to offer advantages over the current use of sedative drugs such as opioids or gabapentanoids for treatment of pain in stroke patients [79,80].”
BackgroundMuanda, F. T., Sood, M. M., Weir, M. A., Sontrop, J. M., Ahmadi, F., Yoo, E. C., Kim, R. B., Silverman, M., Knoll, G. A., & Garg, A. X. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.24892 · Cited by 38
Self-citationMuanda, F. T., Weir, M. A., Ahmadi, F., Sontrop, J. M., Cowan, A., Fleet, J. L., Blake, P. G., & Garg, A. X. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.11.007 · Cited by 34
Self-citationMultimodal Pain Management for Major Joint Replacement Surgery
Goode, V. M., Morgan, B. T., Muckler, V. C. S., Cary, M. P., Zdeb, C. E., & Zychowicz, M. E. (2019) · Orthopaedic Nursing · doi:10.1097/nor.0000000000000525 · Cited by 28
Gabapentinoids for Pruritus in Older Adults: A Narrative Review
Sreekantaswamy, S. A., Mollanazar, N. K., & Butler, D. C. (2021) · Dermatology and Therapy · doi:10.1007/s13555-021-00513-z · Cited by 27
Baclofen has a risk of encephalopathy in older adults receiving dialysis
Chauvin, K., Blake, P. G., Garg, A. X., Weir, M. A., Bathini, L., Dixon, S. N., McArthur, E., Sontrop, J. M., MOIST, L. M., Kim, R. B., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.04.047 · Cited by 25
Self-citationBouchard, J., Yates, C., Calello, D. P., Gosselin, S., Roberts, D. M., Lavergne, V., Hoffman, R. S., Ostermann, M., Peng, A. F., Ghannoum, M., et al. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.06.027 · Cited by 26
“70 Significant alteration in mental status is reported after a single therapeutic dose of gabapenti-noids in maintenance dialysis patients.”
BackgroundThe 2016 CDC Opioid Guideline and Analgesic Prescribing Patterns in Older Adults With Cancer
Rodin, R. A., Li, L., McKendrick, K., Harrison, K. L., Hunt, L. J., Muench, U., Smith, C. B., Aldridge, M. D., & Morrison, R. S. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.9043 · Cited by 18
Gabapentin for alcohol use disorder: A good option, or cause for concern?
Modesto‐Lowe, V., Barron, G. C., Aronow, B., & Chaplin, M. (2019) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.86a.18128 · Cited by 17
Shade, M., Rector, K., & Kupzyk, K. (2021) · JMIR Formative Research · doi:10.2196/26361 · Cited by 19
“Skipping, abruptly stopping, or incorrectly taking gabapentoid doses can increase the risk of experiencing adverse symptoms [32].”
Topical gabapentin solution for the management of burning mouth syndrome: A retrospective study
Gramacy, A., & Villa, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0295559 · Cited by 14
Underutilization of Acetaminophen in Older Adult Trauma Patients
Haines, K., Fuller, M., Antonescu, I., Vaughan, J. G., Raghunathan, K., Cox, C. E., Bartz, R. R., Ohnuma, T., Agarwal, S., & Krishnamoorthy, V. K. (2021) · The American Surgeon · doi:10.1177/00031348211023397 · Cited by 10
“Additionally, we and others have shown that gabapentin-like agents have side effects including synergistic effects on respiratory depression when combined with opioids.(8,9) Multimodal analgesia has been popularized as a means to both improve pain control and decrease opioid exposure.”
BackgroundAnesthesia and Enhanced Recovery After Head and Neck Surgery
Worrall, D. M., Tanella, A., DeMaria, S., & Miles, B. A. (2019) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2019.08.008 · Cited by 10
McCarthy, L. M., Boylan, K. A., & Sarkis, R. A. (2026) · Drugs & Aging · doi:10.1007/s40266-026-01283-z · Cited by 11
Analysis of Adverse Effects of Multimodal Gabapentin in Abdominal Wall Reconstruction
Sarac, B. A., Schoenbrunner, A. R., Brower, K. I., Joshi, G. P., & Janis, J. E. (2022) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000008836 · Cited by 9
“001 Biologic 27 (20) 33 (44) 60 (28) Synthetic 105 (76) 38 (51) 143 (67) Unilateral component separation 38 (28) 12 (16) 50 (24) 0.”
Sharon, C. E., Strohl, C., & Saur, N. M. (2023) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0043-1761151 · Cited by 8
Perioperative medication management for older people
Johnson, S., & Haywood, C. J. (2022) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1834 · Cited by 8
Psychotropic substitutions: Out of the frying pan and into the fire
Reppas‐Rindlisbacher, C. E., Stall, N. M., & Rochon, P. A. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18381 · Cited by 7
“While the benefits of gabapentinoids and valproic acid are questionable, it is clear that they are associated with potential harms including sedation, dizziness, confusion, and worsening functional decline.(15,16) Similar to the case of opioids being substituted for gabapentin, the inverse prescribing trends of antips…”
BackgroundBajracharya, R., & Qato, D. M. (2021) · Journal of Aging and Health · doi:10.1177/0898264320959293 · Cited by 5
“In the older adult population, there is evidence linking gabapentin use to atrial fibrillation (Ortiz de Landaluce et al., 2018), altered mental status (Yeddi et al., 2019), and hospitalization (Fleet et al., 2018).”
BackgroundThe Effect of Concurrent Use of Opioids and Gabapentin on Fall Risk in Older Adults
Painter, J. T., Peng, C., Burlette, M., Clement, C., Luciani, L. L., Azhar, G., & Dayer, L. E. (2024) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2024.2358953 · Cited by 7
“However, higher rates of adverse events are likely to occur when geriatric patients receive gabapentin compared to placebo; therefore, caution must also be taken when prescribing gabapentinoids to geriatric patients (6,7).”
Goswami, S., Ramachandran, S., Sharma, M., & Barnard, M. (2022) · Journal of Pharmacy Practice · doi:10.1177/08971900221087119 · Cited by 4
“Prescribers should be cautious about overlapping prescriptions of these two drugs which potentially contribute to an increased risk of falls, loss of balance, or respiratory depression.(10,11,26) Table 2.”
BackgroundAssessing the Risk for Falls in Older Adults After Initiating Gabapentin Versus Duloxetine
Chaitoff, A., Desai, R. J., Choudhry, N. K., Jungo, K. T., Haff, N., & Lauffenburger, J. C. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-00636 · Cited by 6
“However, although appropriate for certain kinds of pain, newer evidence has suggested that gabapentin may not work for all conditions and is associated with harms, particularly falls, in older adults (10 – 13).”
Multimodal analgesia: Opioid-sparing strategies for pain management
Verla, M. A., & Iqbal, A. (2021) · Seminars in Colon and Rectal Surgery · doi:10.1016/j.scrs.2021.100830 · Cited by 4
Abdullah, S. S., Rostamzadeh, N., Muanda, F. T., McArthur, E., Weir, M. A., Sontrop, J. M., Kim, R. B., Sedig, K., & Garg, A. X. (2024) · Canadian Journal of Kidney Health and Disease · doi:10.1177/20543581231221891 · Cited by 5
“The number of records removed for each exclusion step is shown in Supplemental eFigure 6.”
BackgroundSelf-citationHigher-Dose Sitagliptin and the Risk of Congestive Heart Failure in Older Adults with CKD
Muanda, F. T., Weir, M. A., Bathini, L., Clemens, K. K., Perkovic, V., Sood, M. M., McArthur, E., Sontrop, J. M., Kim, R. B., & Garg, A. X. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08310520 · Cited by 4
Self-citationCannabis use frequency and pain interference among people with HIV
Klepp, T., Heeren, T., Winter, M. R., Lloyd-Travaglini, C. A., Magane, K. M., Rodríguez, E. M. R., Kim, T. W., Walley, A. Y., Mason, T., & Saitz, R. (2023) · AIDS Care · doi:10.1080/09540121.2023.2208321 · Cited by 4
“However, non-opioid medications for pain such as gabapentin have their own risks of addiction, falls, and overdose (Fleet et al., 2018; Kim et al., 2017).”
BackgroundYao, L. Y., Parrish, A. B., Fleshner, P. R., & Zaghiyan, K. N. (2024) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000003435 · Cited by 6
“Patients older than 70 years were excluded because of the reported increased risk of postoperative respiratory suppression 11 and altered mental status 12 with gabapentin use.”
Long-term gabapentin treatment impairs cognitive function in aged mice via tau hyperphosphorylation
Xia, S., You, Z., Wu, X., Yang, J., Wang, S., Li, N., Dai, J., Dong, Y., Chen, L. L., Yan, M., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1616775 · Cited by 3
Patterns of gabapentin prescription and of hospitalization in a national cohort of US Veterans
Levy, D. R., Gordon, K. S., Bastian, L. A., Brandt, C., & Gunderson, C. G. (2024) · Pain Medicine · doi:10.1093/pm/pnae027 · Cited by 3
Kim, T. W., Samet, J. H., Lodi, S., Kimmel, S. D., Forman, L. S., Lira, M. C., Liebschutz, J. M., Williams, E. C., & Walley, A. Y. (2022) · AIDS and Behavior · doi:10.1007/s10461-022-03716-3 · Cited by 3
“Other studies have observed greater overdose risk with increasing dose [22].”
BackgroundResultInfluentialPain Management in the Older Adult
Sapell, D., Hale, C., Takeshita, A., & Copenhaver, D. J. (2023) · Springer eBooks · doi:10.1007/978-3-030-01782-8_90-1 · Cited by 2
Pain Management in the Older Adult
Sapell, D., Hale, C., Takeshita, A., & Copenhaver, D. J. (2024) · Springer eBooks · doi:10.1007/978-3-030-74720-6_90 · Cited by 2
Stefansdottir, A. B., Vieira, L., Johnsen, Á., Isacson, D., Rodríguez-Lorenzo, A., & Mani, M. R. (2024) · Archives of Plastic Surgery · doi:10.1055/s-0043-1777673 · Cited by 2
“Gabapentin, in previous studies, has been shown to be related to altered mental status, primarily in the elderly population; 17 wefoundnosuchcorrelationsinourpopulation.”
Sadeghi, H., Ahmadi, F., McArthur, E., Sontrop, J. M., Abdullah, S. S., Urquhart, B. L., Kim, R. B., & Muanda, F. T. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16365 · Cited by 2
ENĂTESCU, V. R. (2020) · FARMACIA · doi:10.31925/farmacia.2020.6.14 · Cited by 2
“This result is also supported by another research [30].”
ResultSignal detection of adverse events associated with gabapentinoid use for chronic pain
Kuo, Y., Polychronopoulou, E., & Raji, M. A. (2023) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5685 · Cited by 1
“25 In 2008, the FDA reported increased risk of suicidal ideation with use of antiepileptic medications based on 199 placebo-controlled trials 26 ; later observational studies conducted specifically for GABA drugs found both positive and negative evidence of this association.”
BackgroundGabapentinoids in Chronic Kidney Disease: A Closer Look at Respiratory Risk
Harven, L. T., Paxton, R. A., & Giuliano, C. A. (2025) · Annals of Pharmacotherapy · doi:10.1177/10600280251401899 · Cited by 1
“12 Using the electronic medical record (EMR), data were collected via manual review on patient demographics (age, sex, race, height, and weight), relevant past medical history (including COPD, asthma, heart failure, epilepsy, stroke, PE, intracranial hemorrhage, traumatic brain injury, interstitial…”
Free Flap Enhanced Recovery Protocols in Head and Neck Surgery
Balaguru, L., Chow, L., Mifsud, M. J., Feng, A. L., Richmon, J. D., Lobaina, D., Old, M. O., Kakarala, K., Conrad, D. J., & Dziegielewski, P. T. (2024) · Facial Plastic Surgery Clinics of North America · doi:10.1016/j.fsc.2024.07.003 · Cited by 1
Amgen公司的促红细胞生长素(EPO)制剂“Aranesp”II期临床试验取得良好结果
时村聪代 (2006)
Single cycle, low temperature radiofrequency ablation is effective for trigeminal neuralgia
Budisulistyo, T., & Arlina, Y. (2022) · Anaesthesia Pain & Intensive Care · doi:10.35975/apic.v26i5.2024
“Gabapentin (GB) and pregabalin (PG) are less preferred as monotherapy,(9,10) and need caution regarding the kidney and liver functions and mental status changes.(13) Tricyclic antidepressants (TCA) have potent anti-arrhythmia action, sedation, coma, or death in long-term medication.”
BackgroundMuanda, F. T., Weir, M. A., Ahmadi, F., McArthur, E., Sontrop, J. M., Abdullah, S. S., Urquhart, B. L., Sadeghi, H., Kim, R. B., & Garg, A. X. (2024) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2948
Self-citationWhen and how to adapt care in frail older adults
Isenberg, E. E., Marzoughi, M., & Suwanabol, P. A. (2024) · Seminars in Colon and Rectal Surgery · doi:10.1016/j.scrs.2024.101063
Dangpiaei, S., & Al-Mamun, M. (2025) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2025.100618
“60 Previous studies recommended evaluating gabapentin ’ s abuse potential for federal drug scheduling and high-lighted its impact on misuse and diversion rates and the need for public health and law enforcement responses, such as stricter opioid prescribing guidelines, expanded naloxone…”
Sun, S., Donahue, M. A., Rocha, R. B., Sankaranarayanan, M., Newhouse, J. P., Hernández–Díaz, S., Tsai, A. C., Haneuse, S., & Moura, L. M. V. R. (2025) · medRxiv · doi:10.1101/2025.09.23.25336477
Rostamzadeh, N., Sharma, R., Abdullah, S. S., McArthur, E., Chalabianloo, N., Sontrop, J. M., Weir, M. L., Sedig, K., Garg, A. X., & Muanda, F. T. (2025) · JMIR Research Protocols · doi:10.2196/77224
Self-citationThings We Do for No Reason™: Prescribing gabapentinoids for pain
Patel, N. G., Goese, D., Belknap, S. M., Madeira, C. L., & Barsuk, J. H. (2026) · Journal of Hospital Medicine · doi:10.1002/jhm.70286 · Cited by 2
Gutti, S., & Riyadh, S. (2026) · Cureus · doi:10.7759/cureus.109507
“Gabapentinoid categories reflected dose ranges observed within the retrospective study population and literature describing dose-related adverse neurologic effects, misuse potential, and toxicity risk in susceptible patients [2,7,14].”
Trends in Co-Prescribing Opioids and Gabapentinoids Among Medicare Beneficiaries, 2017 to 2022
Raji, M. A., Sujit, A., Westra, J. R., Rajagopal, S., & Kuo, Y. (2026) · Medical Sciences · doi:10.3390/medsci14030345
“On the other hand, approximately 33% of the opioid and GABA user cohort started with a high initial daily GABA dose of 1200 mg or higher, a dose associated with falls/fractures, delirium and hospitalization in older adults [21,22].”
Habib, M., Wojciechowski, A. M., Grabowski, D. C., Normand, S. T., Hsu, J., Zafar, S. F., & Moura, L. M. V. R. (2026) · Neurotrauma Reports · doi:10.1177/2689288x261478748
Long-Term Opioid and Gabapentinoid Related Harms in CKD
Grant, C. H., Livingstone, S. J., Wang, H., Barnett, K. N., Mark, P. B., Colvin, L., & Bell, S. (2026) · Kidney International Reports · doi:10.1016/j.ekir.2026.107085
“53,54 Our study has notable strengths including the use of population-based data with prolonged follow-up.”
Gabapentinoids and Their Use in Alcohol Use Disorders
Henriquez, R., & Mansi, I. A. (2026) · Springer eBooks · doi:10.1007/978-3-031-35658-2_168-1
Medical management in trigeminal neuralgia
Reilly, M. J., Hashimoto, N., Chen, K., & Abd-Elsayed, A. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44891-1.00018-1
Veschio, T., McKendrick, K., Li, L., Harrison, K. L., Hunt, L. J., Muench, U., Smith, C. B., Aldridge, M. D., Morrison, R. S., & Rodin, R. A. (2026) · Journal of General Internal Medicine · doi:10.1007/s11606-026-10932-3
Metadata
- Authors
- Fleet, J. L., Dixon, S. N., Kuwornu, P. J., Dev, V. K., Montero-Odasso, M., Burneo, J., & Garg, A. X.
- Affiliations
- McMaster University (CA)
- Western University (CA)
- Sunnybrook Hospital (CA)
- Corresponding author
- Fleet, Jamie L.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-03-14
- Volume
- 13
- Issue
- 3
- Pages
- e0193134
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5851574
- OpenAlex
- W2793971339
- Cited by
- 60
- References
- 31
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 10 · 2023: 7 · 2022: 7 · 2021: 8 · 2020: 5 · 2019: 5
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Lawson Health Research Institute
- London Health Sciences Centre
- Academic Medical Organization of Southwestern Ontario
- Institute for Clinical Evaluative Sciences
- Ontario Ministry of Health and Long-Term Care
- Canadian Institutes of Health Research
- Schulich School of Medicine and Dentistry
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- gabapentin, altered mental status, older adults, neuropathic pain, drug safety, hospitalization, all-cause mortality, adverse drug reactions, head CT
- MeSH terms
- Gabapentin, Aged, Aged, 80 and over, Amines, Confusion, Cyclohexanecarboxylic Acids, Dizziness, Female, gamma-Aminobutyric Acid, Hospitalization, Humans, Male, Neuralgia, Retrospective Studies, Risk Factors, Sleep Stages, Tomography, X-Ray Computed, Survival Rate, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.